2nsm: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Human carboxypeptidase N (CPN), a member of the CPN/E subfamily of, "regulatory" metallo-carboxypeptidases, is an extracellular glycoprotein, synthesized in the liver and secreted into the blood, where it controls, the activity of vasoactive peptide hormones, growth factors and cytokines, by specifically removing C-terminal basic residues. Normally, CPN, circulates in blood plasma as a hetero-tetramer consisting of two 83 kDa, (CPN2) domains each flanked by a 48 to 55 kDa catalytic (CPN1) domain. We, have prepared and crystallized the recombinant C-terminally truncated, catalytic domain of human CPN1, and have determined and refined its 2.1 A, crystal structure. The structural analysis reveals that CPN1 has a, pear-like shape, consisting of a 319 residue N-terminal catalytic domain, and an abutting, cylindrically shaped 79 residue C-terminal beta-sandwich, transthyretin (TT) domain, more resembling CPD-2 than CPM. Like these, other CPN/E members, two surface loops surrounding the active-site groove, restrict access to the catalytic center, offering an explanation for why, some larger protein carboxypeptidase inhibitors do not inhibit CPN., Modeling of the Pro-Phe-Arg C-terminal end of the natural substrate, bradykinin into the active site shows that the S1' pocket of CPN1 might, better accommodate P1'-Lys than Arg residues, in agreement with CPN's, preference for cleaving off C-terminal Lys residues. Three Thr residues at, the distal TT edge of CPN1 are O-linked to N-acetyl glucosamine sugars;, equivalent sites in the membrane-anchored CPM are occupied by basic, residues probably involved in membrane interaction. In tetrameric CPN, each CPN1 subunit might interact with the central leucine-rich repeat, tandem of the cognate CPN2 subunit via a unique hydrophobic surface patch, wrapping around the catalytic domain-TT interface, exposing the two active, centers.
Human carboxypeptidase N (CPN), a member of the CPN/E subfamily of "regulatory" metallo-carboxypeptidases, is an extracellular glycoprotein synthesized in the liver and secreted into the blood, where it controls the activity of vasoactive peptide hormones, growth factors and cytokines by specifically removing C-terminal basic residues. Normally, CPN circulates in blood plasma as a hetero-tetramer consisting of two 83 kDa (CPN2) domains each flanked by a 48 to 55 kDa catalytic (CPN1) domain. We have prepared and crystallized the recombinant C-terminally truncated catalytic domain of human CPN1, and have determined and refined its 2.1 A crystal structure. The structural analysis reveals that CPN1 has a pear-like shape, consisting of a 319 residue N-terminal catalytic domain and an abutting, cylindrically shaped 79 residue C-terminal beta-sandwich transthyretin (TT) domain, more resembling CPD-2 than CPM. Like these other CPN/E members, two surface loops surrounding the active-site groove restrict access to the catalytic center, offering an explanation for why some larger protein carboxypeptidase inhibitors do not inhibit CPN. Modeling of the Pro-Phe-Arg C-terminal end of the natural substrate bradykinin into the active site shows that the S1' pocket of CPN1 might better accommodate P1'-Lys than Arg residues, in agreement with CPN's preference for cleaving off C-terminal Lys residues. Three Thr residues at the distal TT edge of CPN1 are O-linked to N-acetyl glucosamine sugars; equivalent sites in the membrane-anchored CPM are occupied by basic residues probably involved in membrane interaction. In tetrameric CPN, each CPN1 subunit might interact with the central leucine-rich repeat tandem of the cognate CPN2 subunit via a unique hydrophobic surface patch wrapping around the catalytic domain-TT interface, exposing the two active centers.


==About this Structure==
==About this Structure==
Line 15: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Bode, W.]]
[[Category: Bode, W.]]
[[Category: Deddish, P.A.]]
[[Category: Deddish, P A.]]
[[Category: Erdoes, E.G.]]
[[Category: Erdoes, E G.]]
[[Category: Hoopes, J.T.]]
[[Category: Hoopes, J T.]]
[[Category: Huber, R.]]
[[Category: Huber, R.]]
[[Category: Keil, C.]]
[[Category: Keil, C.]]
[[Category: Maskos, K.]]
[[Category: Maskos, K.]]
[[Category: Skidgel, R.A.]]
[[Category: Skidgel, R A.]]
[[Category: Tan, F.]]
[[Category: Tan, F.]]
[[Category: Than, M.]]
[[Category: Than, M.]]
Line 32: Line 32:
[[Category: zinc peptidase]]
[[Category: zinc peptidase]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 15:35:26 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:10:29 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA